Bing-Neel syndrome presenting with bilateral lumbar radiculopathy: A case report of a rare clinical entity

Neurocirugia (Astur : Engl Ed). 2022 Sep-Oct;33(5):250-253. doi: 10.1016/j.neucie.2021.03.004.

Abstract

The differential diagnosis of bilateral lower extremity weakness is broad. We present a very rare case of a 48-year old male patient, with walking difficulties due to Bing-Neel syndrome. On clinical examination, there was a significant loss of muscle power in all his lower extremities key-muscle groups. The lumbar spine magnetic resonance imaging (MRI) showed only mild degenerative changes, whereas the MRI of the head indicated a diffuse meningeal thickening at the right temporal region, characterized by significant enhancement after contrast administration. Serum protein electrophoresis detected an IgM-kappa monoclonal protein. The patient received intrathecal chemotherapy with methotrexate and cytarabine, and was started on oral ibrutinib 420mg daily. In conclusion, a past medical history of Waldenstrom macroglobulinemia in conjunction with neurological manifestations should alert the treating physician for Bing-Neel syndrome. A complete diagnostic imaging and serologic protocol helps in setting the final diagnosis. Steroids are part of the treatment, but should be given after the diagnosis is set. Neurosurgical intervention is indicated for histologic confirmation in the case of diagnostic uncertainty.

Keywords: Análisis de LCR; Bing–Neel syndrome; CSF analysis; Central nervous system; Dificultades al caminar; Macroglobulinemia de Waldenström; Sistema nervioso central; Síndrome de Bing-Neel; Waldenstrom macroglobulinemia; Walking difficulty.

Publication types

  • Case Reports

MeSH terms

  • Brain Diseases* / diagnosis
  • Brain Diseases* / drug therapy
  • Brain Diseases* / pathology
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Radiculopathy* / etiology
  • Waldenstrom Macroglobulinemia* / complications
  • Waldenstrom Macroglobulinemia* / diagnosis
  • Waldenstrom Macroglobulinemia* / drug therapy